Greg Johnson - Profile and Investment Details

Investor Profile

Greg Johnson is a Venture Capital, Private Equity Firm based in St. Louis, Missouri, United States with a diverse investment portfolio that includes companies such as Chlorogen, Akermin, Travanti Pharma, The Nest Collective, NeuroLutions, Asoyia, Quick Study Radiology, Kereos, Veniti, Zystor, Zeel, Covercress, Kinnos, Plum Organics, CareDox, CS-Keys, Efficas, Singulex, Dreamerz Foods, Benson Hill, Spindrift, Natural Dentist, Veran Medical Technologies, BioClarity, EraGen Biosciences, Toma Biosciences, Brand New Brands, Intellicyt, AirXpandersCleanSlate UV, EndoStim, Attune Foods, Divergence, . Over time, Greg Johnson has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Greg Johnson is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Food & Beverage, Health Care, Genetics, E-commerce, Autoimmune Diseases, Wellness, Women Founded, Consumer Goods, Investment Management, Strategic Partnerships, Education, Retail, Startups, Manufacturing, Biotechnology, Consumer Health, Clean Technology, Genomics, Nutrition, Food and Beverage, Groceries, Consumer Internet, Animal Feed, Agriculture, B2C, Hardware, Personal Care, Digital Health, Oil and Gas, Plant-Based Products, Renewable Energy, Medical, Information Technology, B2B, Health Tech, Acquisitions may find it worthwhile to explore potential connections with Greg Johnson, as their portfolio suggests a familiarity and interest in this area.

Understanding Greg Johnson’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.